Kennedy Capital Management Inc. Boosts Stake in Phibro Animal Health Corporation (PAHC)

Kennedy Capital Management Inc. lifted its stake in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 1.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 99,004 shares of the company’s stock after buying an additional 1,355 shares during the period. Kennedy Capital Management Inc. owned approximately 0.25% of Phibro Animal Health Corporation worth $3,668,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the company. Alps Advisors Inc. lifted its stake in shares of Phibro Animal Health Corporation by 0.3% during the second quarter. Alps Advisors Inc. now owns 17,541 shares of the company’s stock worth $650,000 after buying an additional 46 shares during the period. Louisiana State Employees Retirement System lifted its stake in shares of Phibro Animal Health Corporation by 1.4% during the first quarter. Louisiana State Employees Retirement System now owns 7,500 shares of the company’s stock worth $211,000 after buying an additional 100 shares during the period. Arizona State Retirement System lifted its stake in shares of Phibro Animal Health Corporation by 1.0% during the second quarter. Arizona State Retirement System now owns 9,800 shares of the company’s stock worth $363,000 after buying an additional 100 shares during the period. Municipal Employees Retirement System of Michigan lifted its stake in shares of Phibro Animal Health Corporation by 3.6% during the second quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock worth $162,000 after buying an additional 150 shares during the period. Finally, American Century Companies Inc. lifted its stake in shares of Phibro Animal Health Corporation by 1.1% during the second quarter. American Century Companies Inc. now owns 18,905 shares of the company’s stock worth $700,000 after buying an additional 205 shares during the period. Institutional investors and hedge funds own 48.35% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Kennedy Capital Management Inc. Boosts Stake in Phibro Animal Health Corporation (PAHC)” was first reported by Transcript Daily and is the property of of Transcript Daily. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://transcriptdaily.com/2017/09/17/kennedy-capital-management-inc-boosts-stake-in-phibro-animal-health-corporation-pahc.html.

Phibro Animal Health Corporation (PAHC) opened at 35.75 on Friday. The company’s 50-day moving average is $37.99 and its 200-day moving average is $33.77. The firm has a market capitalization of $1.43 billion, a P/E ratio of 22.20 and a beta of 1.36. Phibro Animal Health Corporation has a 52-week low of $24.83 and a 52-week high of $40.25.

Phibro Animal Health Corporation (NASDAQ:PAHC) last posted its earnings results on Wednesday, August 30th. The company reported $0.39 EPS for the quarter, beating the Zacks’ consensus estimate of $0.35 by $0.04. The firm had revenue of $194.84 million for the quarter, compared to the consensus estimate of $192.47 million. Phibro Animal Health Corporation had a net margin of 8.45% and a return on equity of 47.88%. The company’s revenue was up 3.0% on a year-over-year basis. During the same period last year, the firm posted $0.32 EPS. On average, analysts predict that Phibro Animal Health Corporation will post $1.57 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 27th. Investors of record on Wednesday, September 6th will be paid a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 1.12%. The ex-dividend date is Friday, September 1st. Phibro Animal Health Corporation’s dividend payout ratio is currently 24.69%.

In related news, major shareholder Bfi Co., Llc sold 48,000 shares of the stock in a transaction on Friday, June 30th. The shares were sold at an average price of $37.42, for a total transaction of $1,796,160.00. Following the completion of the sale, the insider now owns 92,000 shares in the company, valued at approximately $3,442,640. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Daniel M. Bendheim sold 5,938 shares of the stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $40.04, for a total transaction of $237,757.52. Following the sale, the vice president now owns 300 shares of the company’s stock, valued at approximately $12,012. The disclosure for this sale can be found here. In the last quarter, insiders have sold 442,448 shares of company stock valued at $16,182,714. 48.09% of the stock is owned by company insiders.

Several equities research analysts have recently commented on the stock. Piper Jaffray Companies set a $42.00 price objective on shares of Phibro Animal Health Corporation and gave the stock a “buy” rating in a research note on Friday, August 25th. Bank of America Corporation reiterated an “underperform” rating and set a $33.00 price objective on shares of Phibro Animal Health Corporation in a research note on Wednesday, August 23rd. BidaskClub downgraded shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 23rd. Finally, Credit Suisse Group downgraded shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and lifted their price objective for the stock from $29.00 to $36.00 in a research note on Friday, June 2nd. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $34.00.

Phibro Animal Health Corporation Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply